Concepedia

Frank Schönsiegel

FS

Statistics

Publications

10

Citations

439

H-Index

10

Active since

2002

Affiliations

Heidelberg University(Current)

German Cancer Research Center

University Hospital Heidelberg

Frank Schönsiegel is an author at Heidelberg University specializing in medicine, oncology, and cancer stem cells.

Publications per year

2002–2017

10

Publications

10

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

Carina Hage, Vanessa Rausch, Nathalia A. Giese et al. · Cell Death and Disease · 2013 · 117 citations · Full text

, , +17

Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine

Orkhan Isayev, Vanessa Rausch, Nathalie Bauer et al. · Oncotarget · 2014 · 66 citations · Full text

, , +17

Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1

Li Liu, Ewa Aleksandrowicz, Frank Schönsiegel et al. · Cell Death and Disease · 2017 · 61 citations · Full text

, , +16

Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells

Sabrina Labsch, Li Liu, Nathalie Bauer et al. · International Journal of Oncology · 2014 · 59 citations · Full text

, , +17

Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3)

Stephanie Sieger, Shiming Jiang, Frank Schönsiegel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 39 citations

, , +9

1–5 of 10